Resources

This year RNID have been chosen as the BIA’s charity partner of the year. This partnership gives us a unique platform to shine the light on the huge opportunities that exist for hearing therapeutics.

UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.

​​​​Herbie Lambden, Senior Policy and Public Affairs Executive at the BIA, provides a rundown of the BIA Committee Summit, which took place in Westminster on 21 February.

Brainomix's software is an award-winning imaging biomarker that uses mathematical algorithms to extract information from medical images, to enable precision medicine for better treatment decisions in stroke and lung fibrosis.

Momentum on the pension investment agenda, AI Summit and health data, and West Midlands make a splash in Westminster.

AI, gene editing, engineering biology, and investor interest drive growth in UK bioeconomy.

As the ‘back to school’ emails start to roll in and we come to terms with the end of summer, at BIA we are putting the finishing touches to a packed autumn agenda of events and thought leadership. With September just around the corner, it’s worth having a look at what we have planned and ensuring you book your place or get in touch to find out more.